UG Healthcare (8K7.SI, SES) +4.11% on 463,900 shares intraday: watch S$0.07

The 8K7.SI stock gained 4.11% intraday, trading at S$0.076 on a volume spike of 463,900 shares on the Singapore Exchange (SES). This volume places UG Healthcare Corporation Limited (8K7.SI) among today’s high-volume movers and pushed the price above yesterday’s close of S$0.073. Traders are watching intraday support near S$0.07 and resistance at the session high S$0.08. We track how volume, technicals and recent fundamentals drive the move for short-term trading and position-setting as an AI-powered market analysis platform.

8K7.SI stock intraday volume and price action

UG Healthcare (8K7.SI) opened at S$0.074 and hit a day high of S$0.08 while the day low was S$0.074. Volume of 463,900 shares is below the 50-day average volume of 756,157 but still notable for a low-priced stock and is driving the intraday 4.11% lift. Market cap stands at S$47,410,762.00 and the stock has a 52-week range of S$0.072 to S$0.124.

8K7.SI stock fundamentals and valuation

Fundamentals show mixed signals: EPS is -0.01 and reported PE is -7.60, reflecting recent losses. Price-to-book is 0.30 and price-to-sales is 0.33, indicating the stock trades at a discount to book value. Key balance-sheet ratios include a current ratio of 2.70 and debt-to-equity of 0.30, which give some short-term liquidity comfort despite negative operating cash flow per share of -0.01.

8K7.SI stock technicals, support and resistance

Technicals show a short-term oversold bounce: RSI is 33.75 and the stock sits near its Bollinger middle band at S$0.08. The 50-day average S$0.09 and 200-day average S$0.10 act as nearby resistance. Immediate support is S$0.07; a break below that opens the year low S$0.072, while reclaiming S$0.09 could attract short-term momentum traders.

Meyka AI rating and forecast for 8K7.SI stock

Meyka AI rates 8K7.SI with a score out of 100: 63.29 (B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of S$0.102, a ~34.21% implied upside from the current S$0.076, though forecasts are model-based projections and not guarantees.

Sector context, inventory cycles and risks for 8K7.SI stock

UG Healthcare operates in the Healthcare sector (Medical – Instruments & Supplies) where the sector average PE is about 21.53, making 8K7.SI cheaper on valuation metrics. Operational risks include long days-of-inventory (215 days) and DSO of 120 days, which pressure working capital. External risks are glove market pricing swings and order cycles; strengths include diversified export markets and a tangible book value per share of 0.22.

Trading strategy for high-volume movers like 8K7.SI stock

For intraday traders, treat today’s move as volume-driven range play: use stops below S$0.07 and target near S$0.09–S$0.10 for short-term trades. Longer-term investors should weigh the Meyka grade, negative EPS, and cash flow metrics before adding to positions. Monitor headlines and SGX announcements and use volume confirmation before scaling in.

Final Thoughts

Key takeaways: the 8K7.SI stock recorded a 4.11% intraday rise to S$0.076 on 463,900 shares, driven by short-term buying into oversold technicals. Fundamentals remain mixed: negative EPS (-0.01) and weak operating cash flow per share contrast with a low price-to-book (0.30) and a healthy current ratio (2.70). Meyka AI’s forecast model projects a yearly price of S$0.102, implying roughly a 34.21% upside from the current price; forecasts are model-based projections and not guarantees. Realistic near-term price targets we see are S$0.06 (downside support), S$0.09 (short-term resistance), and S$0.12 (bull case aligned with the 52-week high). Traders should watch volume confirmation, maintain tight risk controls around S$0.07, and track SGX updates and sector trends. For more data and live signals see the company site and our Meyka stock page for 8K7.SI

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.